Figure 1From: A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophagesStructural formulae: a. The structural formula of NO-aspirin, NCX4016. b. The general structural formula of a furoxan-aspirin hybrid drug. c. The structural formulae of furoxans (B8 and B7), their NO-free equivalents, the furazans (B16 and B15) and, for comparison, aspirin.Back to article page